Clinical trial

The Swedish BioFINDER - Preclinical AD Study

NCT06121544

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2022-04-01

PhaseN/A

Study timeline

Study start (actual)2022-04-01Date precision: day

Registry last updated2026-04-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer Diseaseunresolved

Mild Cognitive Impairmentunresolved

Mild Dementiaunresolved

Interventions

Plasma tauDIAGNOSTIC_TEST

Plasma β-Amyloid 42/40 (Aβ42/Aβ40)DIAGNOSTIC_TEST

Flutemetamol F18 InjectionDIAGNOSTIC_TEST

[18F]-RO6958948 InjectionDIAGNOSTIC_TEST

Magnetic resonance imaging (MRI)DIAGNOSTIC_TEST

Sponsors & collaborators

Skane University Hospitallead sponsor

Lund Universitycollaborator

Mapped research locations

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06121544 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.